Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional Accepts healthy volunteers

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ClinicalTrials.gov ID: NCT07654374

Public ClinicalTrials.gov record NCT07654374. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 8:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-Term Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Multiple Maintenance Doses of Oral Once Daily Aleniglipron for Chronic Weight Management in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Study identification

NCT ID
NCT07654374
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Industry
Enrollment
1,100 participants

Conditions and interventions

Interventions

  • aleniglipron Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 79 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2026
Primary completion
Aug 31, 2028
Completion
Oct 31, 2028
Last update posted
Jun 21, 2026

2026 – 2028

United States locations

U.S. sites
74
U.S. states
30
U.S. cities
70
Facility City State ZIP Site status
ACCOMPLISH-2 Research Site Birmingham Alabama 35242
ACCOMPLISH-2 Research Site Chandler Arizona 85225
ACCOMPLISH-2 Research Site Phoenix Arizona 85028
ACCOMPLISH-2 Research Site Sun City West Arizona 85375
ACCOMPLISH-2 Research Site Tucson Arizona 85741
ACCOMPLISH-2 Research Site Little Rock Arkansas 72211
ACCOMPLISH-2 Research Site Escondido California 92025
ACCOMPLISH-2 Research Site Fountain Valley California 92708
ACCOMPLISH-2 Research Site Lake Forest California 92630
ACCOMPLISH-2 Research Site Rolling Hills Estates California 90274
ACCOMPLISH-2 Research Site San Diego California 92108
ACCOMPLISH-2 Research Site San Diego California 92123
ACCOMPLISH-2 Research Site Tustin California 92780
ACCOMPLISH-2 Research Site Waterbury Connecticut 06708
ACCOMPLISH-2 Research Site Clearwater Florida 33756
ACCOMPLISH-2 Research Site Fort Myers Florida 33912
ACCOMPLISH-2 Research Site Jacksonville Florida 32216
ACCOMPLISH-2 Research Site Leesburg Florida 34748
ACCOMPLISH-2 Research Site Miami Florida 33136
ACCOMPLISH-2 Research Site Ocala Florida 34470
ACCOMPLISH-2 Research Site Ocoee Florida 34761
ACCOMPLISH-2 Research Site Pembroke Pines Florida 33027
ACCOMPLISH-2 Research Site Atlanta Georgia 30329
ACCOMPLISH-2 Research Site Columbus Georgia 31904
ACCOMPLISH-2 Research Site Lawrenceville Georgia 30046
ACCOMPLISH-2 Research Site Union City Georgia 30291
ACCOMPLISH-2 Research Site Woodstock Georgia 30189
ACCOMPLISH-2 Research Site Meridian Idaho 83646
ACCOMPLISH-2 Research Site Des Moines Iowa 50314
ACCOMPLISH-2 Research Site Iowa City Iowa 52242
ACCOMPLISH-2 Research Site Wichita Kansas 67218
ACCOMPLISH-2 Research Site Silver Spring Maryland 20901
ACCOMPLISH-2 Research Site Methuen Massachusetts 01844
ACCOMPLISH-2 Research Site Mankato Minnesota 56001
ACCOMPLISH-2 Research Site Minneapolis Minnesota 55423
ACCOMPLISH-2 Research Site Gulfport Mississippi 39503
ACCOMPLISH-2 Research Site Ridgeland Mississippi 39157
ACCOMPLISH-2 Research Site Chesterfield Missouri 63005
ACCOMPLISH-2 Research Site City of Saint Peters Missouri 63303
ACCOMPLISH-2 Research Site Hazelwood Missouri 63042
ACCOMPLISH-2 Research Site Springfield Missouri 65807
ACCOMPLISH-2 Research Site St Louis Missouri 63141
ACCOMPLISH-2 Research Site Missoula Montana 59804
ACCOMPLISH-2 Research Site Omaha Nebraska 68105
ACCOMPLISH-2 Research Site Las Vegas Nevada 89128
ACCOMPLISH-2 Research Site Albany New York 12206
ACCOMPLISH-2 Research Site Albany New York 12208
ACCOMPLISH-2 Research Site Brooklyn New York 11220
ACCOMPLISH-2 Research Site The Bronx New York 10455
ACCOMPLISH-2 Research Site Charlotte North Carolina 28210
ACCOMPLISH-2 Research Site Durham North Carolina 27710
ACCOMPLISH-2 Research Site Fayetteville North Carolina 28304
ACCOMPLISH-2 Research Site Morehead City North Carolina 23730
ACCOMPLISH-2 Research Site Winston-Salem North Carolina 27104
ACCOMPLISH-2 Research Site Columbus Ohio 43213
ACCOMPLISH-2 Research Site Moore Oklahoma 73160
ACCOMPLISH-2 Research Site Tulsa Oklahoma 74133
ACCOMPLISH-2 Research Site Yukon Oklahoma 73099
ACCOMPLISH-2 Research Site Portland Oregon 97202
ACCOMPLISH-2 Research Site Philadelphia Pennsylvania 19152
ACCOMPLISH-2 Research Site Greer South Carolina 29651
ACCOMPLISH-2 Research Site Nashville Tennessee 37203
ACCOMPLISH-2 Research Site Austin Texas 78704
ACCOMPLISH-2 Research Site Farmers Branch Texas 75234
ACCOMPLISH-2 Research Site Houston Texas 77040
ACCOMPLISH-2 Research Site Houston Texas 77054
ACCOMPLISH-2 Research Site San Antonio Texas 78229
ACCOMPLISH-2 Research Site San Antonio Texas 78230
ACCOMPLISH-2 Research Site Wylie Texas 75098
ACCOMPLISH-2 Research Site Salt Lake City Utah 84107
ACCOMPLISH-2 Research Site Burke Virginia 22015
ACCOMPLISH-2 Research Site Manassas Virginia 20110
ACCOMPLISH-2 Research Site Suffolk Virginia 23435
ACCOMPLISH-2 Research Site Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07654374, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2026 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07654374 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →